Viewing Study NCT05156034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-01-07 @ 7:23 PM
Study NCT ID: NCT05156034
Status: TERMINATED
Last Update Posted: 2023-03-13
First Post: 2021-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
Sponsor: Sarkana Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module